Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.
about
Polyamines and Gut Mucosal Homeostasis.Oral putrescine restores virulence of ornithine decarboxylase-deficient Leishmania donovani in miceDefining the role of polyamines in colon carcinogenesis using mouse models.DFMO: targeted risk reduction therapy for colorectal neoplasia.Dietary polyamine intake and colorectal cancer risk in postmenopausal womenSpermine synthase overexpression in vivo does not increase susceptibility to DMBA/TPA skin carcinogenesis or Min-Apc intestinal tumorigenesis.Dietary polyamine intake and risk of colorectal adenomatous polypsTargeting polyamines and inflammation for cancer preventionRole of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas.Identification and characterization of a diamine exporter in colon epithelial cellsCombination chemoprevention for colon cancer targeting polyamine synthesis and inflammation.Polyamines as mediators of APC-dependent intestinal carcinogenesis and cancer chemoprevention.Cancer chemoprevention locks onto a new polyamine metabolic target.Polyamine catabolism in carcinogenesis: potential targets for chemotherapy and chemoprevention.Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models.Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.Putrescine production via the agmatine deiminase pathway increases the growth of Lactococcus lactis and causes the alkalinization of the culture medium.Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model.
P2860
Q34186523-10193C5A-FD39-405B-B715-9491CC2E1F71Q34587695-F5F7386A-FFC3-433D-A635-549CDF3813C5Q35064943-2620B2BC-F1E9-41EB-B44C-F72C8E4B3563Q35583635-41D1E12F-C26C-4DBA-905C-0B1F3E51182BQ35891459-7D827831-695C-4B70-9219-D49C5B6DB614Q35925417-A36F5AA5-F33E-422F-823C-83CE7C650482Q36030441-BA0B43DD-7CC1-4BFF-A0BB-8DF39B94A076Q36653461-5C6DD6CB-6F86-45ED-B0D2-2E8614E14AFCQ36671933-F385564E-EC38-4401-A7E7-D505FB8580B5Q36897622-16E62C01-2588-4FCE-BA68-A17AE15FDD57Q37152797-E482AF7E-D17E-44B2-8086-ECF61809173DQ37679988-9591DED7-9925-4DAC-9D36-E13E0BCCCE9BQ37681944-E94208AE-1C31-43A2-945E-ECCF55580596Q38114862-346267BC-431D-44BE-B59B-54AE733AD236Q39873234-ED0A6FA2-B2EC-4350-B577-3A52ABD00F28Q45329573-B47A483B-B3AB-42B5-80A7-B347A63EFBB1Q46822148-AEB5533D-F14C-4052-9869-3BD9D3E36F08Q48021881-7CDFC338-C1BB-4221-B25D-F672E39ACE79
P2860
Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@ast
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@en
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@nl
type
label
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@ast
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@en
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@nl
prefLabel
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@ast
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@en
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@nl
P2093
P2860
P1433
P1476
Dietary putrescine reduces the ...... amilial adenomatous polyposis.
@en
P2093
David E Stringer
David G Besselsen
Eugene W Gerner
Jose L Padilla-Torres
Jose M Guillen-R
Karen A Blohm-Mangone
Natalia A Ignatenko
Upal K Basu Roy
P2860
P304
P356
10.1207/S15327914NC5602_8
P577
2006-01-01T00:00:00Z